Skip to content
OpenCapital
Get started

Chemed CHE Increase (Decrease) in Accounts Receivable

Increase (Decrease) in Accounts Receivable at other companies

HCA Healthcare logo
HCA HealthcareHCA
——

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's increase (decrease) in accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's increase (decrease) in accounts receivable?
Chemed (CHE) reported increase (decrease) in accounts receivable of $32.9M in Q1 2026.
How has Chemed's increase (decrease) in accounts receivable changed year-over-year?
Chemed's increase (decrease) in accounts receivable decreased by 51.2% year-over-year, from $67.42M to $32.9M.
What is the long-term trend for Chemed's increase (decrease) in accounts receivable?
Over 3 years (2021 to 2024), Chemed's increase (decrease) in accounts receivable has grown at a 8.2% compound annual growth rate (CAGR), from $8.43M to -$10.68M.
What does increase (decrease) in accounts receivable mean?
The net change in the amount owed to the company by customers for goods or services delivered on credit. A significant increase may indicate aggressive revenue recognition or challenges in collecting payments, while a decrease suggests improved cash conversion efficiency.